In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18) - Wikidata - awgldk - TriplyDB

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

http://www.wikidata.org/entity/Q24630918

about

18F PET ligands for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Untangling tau imaging Insight into the Molecular Imaging of Alzheimer's Disease The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Applications of in vivo imaging in the evaluation of the pathophysiology of viral and bacterial infections and in development of countermeasures to BSL3/4 pathogens Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche Early failure of the default-mode network and the pathogenesis of Alzheimer's disease Brain imaging in Alzheimer disease Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Brain PET in the diagnosis of Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Nuclear imaging modalities for cardiac amyloidosis Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease 18F-florbetaben Aβ imaging in mild cognitive impairment Molecular Structure of Aggregated Amyloid-β: Insights from Solid-State Nuclear Magnetic Resonance Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain Contributions of academic laboratories to the discovery and development of chemical biology tools Quantitative amyloid imaging using image-derived arterial input function PET amyloid-beta imaging in preclinical Alzheimer's disease Cortical β-amyloid levels and neurocognitive performance after cardiac surgery.Meditation and neurodegenerative diseases.Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease Spectral and complexity analysis of scalp EEG characteristics for mild cognitive impairment and early Alzheimer's disease.Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.Biomarkers in frontotemporal lobar degenerations--progress and challenges.Correlation between two methods of florbetapir PET quantitative analysis.Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications.Unveiling molecular events in the brain by noninvasive imaging.Radiosyntheses using fluorine-18: the art and science of late stage fluorination Imaging approaches for dementia.Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography.Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population

P2860

Q26472008-5E4FD354-C05F-410E-BAD9-8A93B02ABCBD Q26739091-3A38E4D6-EFCA-45D7-B5B1-16076ED204E0 Q26765945-923DCD17-5558-472A-9685-582F8621E298 Q26830467-1DB45E60-0B96-4A9B-BEDF-8E3E5ADC5027 Q26830740-E303D231-7E6E-4BAB-8FA0-76E38BE5D1B2 Q26852810-7FAB9361-48C0-42C7-A949-EE14B7A042E4 Q26861645-9838981B-00BD-45C6-BE55-FBC9AD6CC207 Q26862463-24F627E5-619D-40CC-A658-6B35A007B70F Q26996299-09AF356E-02ED-48C5-BB48-C5049E79C4CE Q27009411-7FB7E29B-B13E-42CB-AACC-751C59DA1FE4 Q27011549-DA7785A9-8214-4739-962A-748F4EB424CD Q27012742-8FC0B06E-07BD-4A50-A468-928766564C0F Q27024756-D9C7ECAE-0FEB-4925-8225-AE2580AE0C86 Q27309046-F849C697-491D-4872-9EB5-15F9A5E130CC Q27499311-2A453EC8-732A-4E58-8DA5-1A49B32E886F Q28066391-01D0DACA-28ED-422E-A53F-856F0DF476BC Q28085541-D0266433-B0EE-4B1E-8E36-5AEA8F4A318E Q28389188-8CCC1FFE-512B-4350-B729-F01046729170 Q28545789-D5E6EA17-3D73-4BBD-AC22-090CA18950BB Q30040695-D4E94B96-39DA-4F9F-B7E4-BA90CDB0141F Q30546198-A02382BB-1C8F-4907-9D04-DFDB72FA0EC2 Q30660151-8866BFE6-065D-4952-8872-EC55C35ED528 Q30680866-0A14709C-424E-43E8-9818-724172F3F380 Q30945416-BE1434B6-0686-48DA-81DC-FFD565B2A051 Q31025427-10131465-12DC-43D1-8661-AE8878FE1295 Q33614462-E15699FB-8415-4A03-9F17-ED1B61F46134 Q33683377-47CA37F5-A1A2-4948-8704-8A4CA133EC52 Q33727909-4608B44B-388D-428F-819B-412CDB81917E Q33747987-074F5B8B-9C27-4882-93F2-3A62B4405DD8 Q33893515-571B0EE1-D566-4E87-BC83-C61BE2788224 Q33905494-13B3A2A3-8EAF-4AD6-985F-8C523214DEE4 Q33968419-C0DB9C07-0CE4-427A-A9CE-8B99ACA7F86E Q34046040-5B4ACD3D-4CB2-4E7D-9A26-3DDD50C09D23 Q34074437-A81BFA99-D26B-438E-8DFB-AF64470D9CF7 Q34089121-2F0EA3F1-1946-418D-98D0-AF435A27188E Q34216798-D57245AE-3AD5-4CCB-A2BF-3D8EDACDC721 Q34296479-C7BE709E-4275-442E-B51B-B991E92352C7 Q34378321-E128EAE1-5B7B-415F-BE7A-D13B32CB775D Q34423050-7CD35F95-ABF3-4548-9BCB-C509034757F2 Q34630235-CA4EBC5B-7F64-4692-A6D1-CBA20194D5A3

P2860

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

http://www.wikidata.org/entity/Q24630918

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@ast

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@en

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@nl

type

label

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@ast

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@en

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@nl

prefLabel

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@ast

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@en

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@nl

P1433

Q24630918-671BA468-2B89-4F06-8676-091DDA2C67C3

P1476

Q24630918-BDF2DC67-8ED7-472D-B78C-8A74930A3FEE

P2093

Q24630918-03EF2D05-D9BA-40BA-88C1-F817BD0249BD

Q24630918-1266245A-47D8-495C-BEF2-4AC8F2C2B6A9

Q24630918-152259DC-17FB-4BBC-9E44-E9C6F6D39F15

Q24630918-27A77F5C-BE84-490A-8BB2-BAB03E3D361A

Q24630918-2F002F87-741E-4179-A166-9CA8F505A044

Q24630918-569CF04C-6B9A-4FD3-9E19-09C9EBA5FB7C

Q24630918-5D08A54E-5A63-4744-8430-31825C1058B3

Q24630918-8018584D-33D6-4787-BC20-8BB79B1CD77C

Q24630918-88885822-CA1A-48FB-98FA-3EAF72EE9F52

Q24630918-8916C4E6-3D88-4BF3-92EE-7DC2A914AD43

P2860

Q24630918-0483C45C-1B6F-486A-85D2-AD7B2ABA5AA1

Q24630918-05D24E2A-4A26-42CA-A75A-1061D7474796

Q24630918-0B3E1BB1-E976-43B5-9DE5-0143D629C5A2

Q24630918-1436F3F4-1FB0-49D2-9BFE-97F421AE4394

Q24630918-18470F07-309C-4C98-88D7-9613C50803AF

Q24630918-32DD243E-CAA8-4022-BF8F-13CE57310FCE

Q24630918-35F254E5-27FD-40A5-970E-6F8F348E3A6D

Q24630918-38C5F7D3-B2E9-4F4E-A8F6-AF2764B31806

Q24630918-3AFBF490-9FBA-4C9E-8C81-A657D3FB895E

Q24630918-56337F3E-8A63-44A0-896D-CD00872219DC

P304

Q24630918-DDFD2BCF-5B66-42C1-A51A-715D4B7999B3

P31

Q24630918-2BC22E6F-51B7-4F90-8CC6-08D9C114D523

P3181

Q24630918-81FA85BB-A8D9-4C19-A1D5-B58564985B19

P356

Q24630918-9C299073-3DC5-4438-AE7D-EB7E99FD2FED

P407

Q24630918-73F57E24-EA81-424F-9691-16564BA08CF0

P433

Q24630918-E96ED75E-A3DA-4E9B-A769-4B1588FCB853

P478

Q24630918-992C8744-3973-47F1-8892-069769A62101

P50

Q24630918-3CB7D49B-16F8-4A9B-AB79-8C687CD6212E

P577

Q24630918-3B0A4896-65EC-4BDC-BB57-93E8EBB051A3

P5875

Q24630918-940D8F9C-908C-414A-A184-FF788E5A67AB

P698

Q24630918-DA8C1DA7-1865-447E-A9F0-ADB9157630E1

P921

Q24630918-85577723-3AB7-4CAA-8D29-AFA6EC99508B

P932

Q24630918-D243BDE2-BF0E-4E30-BB4B-E512665F03F1

P3181

P356

JNUMED.109.069088

P1433

The Journal of Nuclear Medicine

P1476

In vivo imaging of amyloid dep ...... (florbetapir [corrected] F 18)

@en

P2093

Abhinay D Joshi

http://www.w3.org/2001/XMLSchema#string

Anil Kumar

http://www.w3.org/2001/XMLSchema#string

Ayon Nandi

http://www.w3.org/2001/XMLSchema#string

Constantine Lyketsos

http://www.w3.org/2001/XMLSchema#string

Daniel M Skovronsky

http://www.w3.org/2001/XMLSchema#string

Dean F Wong

http://www.w3.org/2001/XMLSchema#string

Hank F Kung

http://www.w3.org/2001/XMLSchema#string

Hayden T Ravert

http://www.w3.org/2001/XMLSchema#string

James R Brasić

http://www.w3.org/2001/XMLSchema#string

John Hilton

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

The precuneus: a review of its functional anatomy and behavioural correlates

Diagnosis of Alzheimer's disease in a community hospital-based brain bank program.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease.

Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians.

Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators.

Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease

P304

913-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

598368

http://www.w3.org/2001/XMLSchema#string

P356

10.2967/JNUMED.109.069088

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

Vanessa Raymont

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44629792

http://www.w3.org/2001/XMLSchema#string

P698

20501908

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3101877

http://www.w3.org/2001/XMLSchema#string